Skip to main content
Caplight Logo









Abarceo Pharma

Abarceo Pharma

Private
MalmöHealthcare & Life Scienceshttps://www.abarceo.com/

Last Round

VC Round

Oct 27, 2025

Total Funding Raised

$2.56M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Abarceo Pharma is a biotechnology company developing a small molecule technology platform for the treatment of mitochondrial dysfunction, with an initial focus on Type 2 Diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall molecule therapeuticsmitochondrial dysfunctiontype 2 diabetesT2Dbeta cell functionVDAC1 proteinpre-clinical researchbiotech startupmetabolic diseasedrug licensingpharma partnershiptherapeutic platformmetabolic comorbidities

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abarceo Pharma Comparables

Compare Abarceo Pharma with similar companies based on industry and business-model similarity.

Abarceo Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pharmasaga Co., Ltd.
85%
MitoRx Therapeutics
81%
Mito BioPharma
77%

Abarceo Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 27, 2025
Private EquityDec 6, 2024
SeedMar 1, 2021

Key People

Founding team and executive leadership

Adam Bruce

Chief Executive Officer, Chairman

Executive Team

Abarceo Pharma Investors

Notable investors and investment history

Abarceo Pharma investors
InvestorRounds
Cardeon ABPrivate Equity
Almi Invest ABSeed
LU VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 27, 2025

    Raised a VC Round with investment from lsi-epsilon.

  • May 1, 2025

    Monthly visitors grew 230% MoM, reaching 1.7K.

Abarceo Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Abarceo Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abarceo Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersMalmö
Employee Range10
Year Founded2017
Last FundingOct 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?